| Catalog No. |
TD-JN076016 |
| Species reactivity |
P. aeruginosa |
| Applications |
Research Grade Biosimilar |
| Host species |
Humanized |
| Isotype |
VH-CH1-VH-V-KAPPA-CH2-CH3 |
| Expression system |
Mammalian Cells |
| Clonality |
Monoclonal |
| Target |
PcrV & Psl |
| Endotoxin level |
Please contact the lab for this information. |
| Purity |
>95% purity as determined by SDS-PAGE. |
| Purification |
Protein A/G, purified from cell culture supernatant. |
| Accession |
O30527 |
| Form |
Liquid |
| Storage buffer |
0.01M PBS,pH7.4. |
| Stability and Storage |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
| Alternate Names |
Bispecific,MEDI3902,CAS:1800381-36-5 |
| Background |
Gremubamab (MEDI3902) is a humanized IgG1 kappa anti-PcrV/Psl monoclonal antibody. Gremubamab binds to the PA PcrV protein and Psl exopolysaccharide. Gremubamab has the potential for the research of pseudomonas aeruginosa infections. |
| Note |
For research use only. Not for use in clinical or therapeutic applications. |